Avellino
Avellino uniquely offer personalised genetic testing and gene therapy for the prediction and
prevention of eye care conditions.
Avellino Labs is a genetic services provider specializing in genetic diagnostics, data, and therapy development. Genetic tests like ours allow patients to discover their diseases earlier, leading to greater treatment options and overall better care.
Avellino introduced the world’s first DNA exam that confirms the presence of genetic indicators that are positively associated with corneal diseases, providing life-changing information for patient treatment decisions and follow-up care.
We are also pioneering CRISPR gene editing technology to manage and potentially cure diseases, such as lattice corneal dystrophy, granular corneal dystrophy, and Reis-Bucklers dystrophy.
